Lethal tuberculosis in interleukin-6-deficient mutant mice

被引:283
作者
Ladel, CH
Blum, C
Dreher, A
Reifenberg, K
Kopf, M
Kaufmann, SHE
机构
[1] UNIV ULM,DEPT IMMUNOL,D-89070 ULM,GERMANY
[2] UNIV ULM,CENT ANIM FACIL,D-89070 ULM,GERMANY
[3] MAX PLANCK INST INFECT BIOL,BERLIN,GERMANY
[4] BASEL INST IMMUNOL,BASEL,SWITZERLAND
关键词
D O I
10.1128/IAI.65.11.4843-4849.1997
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tuberculosis is a chronic infectious disease which causes major health problems globally. Acquired resistance is mediated by T lymphocytes and executed by activated macrophages. In vitro studies have emphasized the importance of macrophage activation for mycobacterial growth inhibition. In vivo, the protective host response is focused on granulomatous lesions in which Mycobacterium tuberculosis is contained. A cellular immune response of the T helper 1 (Th1) type is considered central for control of tuberculosis. Using interleukin-6 (IL-6)-deficient mice, we here demonstrate a crucial role of this pluripotent cytokine in protection against M. tuberculosis but not against Mycobacterium bovis EGG. Infection with M. tuberculosis was lethal for the IL-6-deficient mice at inocula that were still controlled by IL-6-competent mice. Spleen cells from M. tuberculosis-infected IL-6(-/-) mouse mutants produced elevated levels of IL-4 and reduced levels of gamma interferon compared to the control levels. Cytofluorometric analyses of spleen cells from M. tuberculosis-infected mice revealed more-profound alterations in T-cell ratios in IL-6(-/-) mice than in control mice. We assume that IL-6 contributes to host resistance by its proinflammatory activity and by its influence on cytokine secretion.
引用
收藏
页码:4843 / 4849
页数:7
相关论文
共 55 条
[1]  
AKIRA S, 1992, IMMUNOL REV, V127, P26
[2]   Mechanisms of phagocytosis [J].
Allen, LAH ;
Aderem, A .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (01) :36-40
[3]  
APPELBERG R, 1994, IMMUNOLOGY, V82, P361
[4]  
Bermudez Luiz E., 1995, Trends in Microbiology, V3, P22, DOI 10.1016/S0966-842X(00)88864-2
[5]   INTERLEUKIN-6 IS REQUIRED IN-VIVO FOR THE REGULATION OF STEM-CELLS AND COMMITTED PROGENITORS OF THE HEMATOPOIETIC SYSTEM [J].
BERNAD, A ;
KOPF, M ;
KULBACKI, R ;
WEICH, N ;
KOEHLER, G ;
GUTIERREZRAMOS, JC .
IMMUNITY, 1994, 1 (09) :725-731
[6]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[7]  
Bothamley GH, 1996, TRENDS MICROBIOL, V4, P95
[8]   CHARACTERIZATION OF THE MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME AND EVIDENCE THAT PHAGOSOMAL MATURATION IS INHIBITED [J].
CLEMENS, DL ;
HORWITZ, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :257-270
[9]   EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE [J].
COLDITZ, GA ;
BREWER, TF ;
BERKEY, CS ;
WILSON, ME ;
BURDICK, E ;
FINEBERG, HV ;
MOSTELLER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :698-702
[10]  
COOPER AM, 1995, IMMUNOLOGY, V84, P423